Evidence map›Paper›PMID 27496039›Full record

ReviewThe oncologist2016

Preventing and Managing Toxicities of High-Dose Methotrexate.

Scott C Howard, John McCormick, Ching-Hon Pui, Randall K Buddington, R Donald Harvey

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in The oncologist, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06217224 (Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma Undergoing High Doses of Methotrexate), which is not on this map. Cited by 392 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
392citing papers in PubMed, 6 pooled it
38.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06217224 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma Undergoing High Doses of Methotrexate

TypeinterventionalSponsorInstituto Nacional de Cancer, BrazilRan2022 to 2025Enrolled53ConditionsMucositis OralArmsPreventive photobiomodulation Therapy (PBMT)
3 · Its place in the literature

Who cites it

392 citing papers in PubMed, 6 syntheses or guidelines pooled it, 866 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. A Case series of Acute Methotrexate Toxicity.Annals of African medicine · 2026
    Article
  19. Article
  20. Article

332 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Scott C HowardSchool of Health Studies, University of Memphis, Memphis, Tennessee, USA Scott.howard@worldchildcancer.us.
John McCormickDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, New York, New York, USA.
Ching-Hon PuiDepartment of Oncology, St. Jude Children's Research Hospital, New York, New York, USA.
Randall K BuddingtonSchool of Health Studies, University of Memphis, Memphis, Tennessee, USA.
R Donald HarveyDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
St. Jude Children's Research Hospital · USEmory University · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

: High-dose methotrexate (HDMTX), defined as a dose higher than 500 mg/m IMPLICATIONS FOR PRACTICE: High-dose methotrexate (HDMTX), defined as a dose higher than 500 mg/m

Indexed as

Acute Kidney InjuryAntimetabolites, AntineoplasticBone MarrowChemical and Drug Induced Liver InjuryCrystallizationgamma-Glutamyl HydrolaseHumansLeucovorinMethotrexateMucositisAntimetabolites, Antineoplasticgamma-Glutamyl HydrolaseLeucovorinMethotrexateAcute kidney injuryGlucarpidaseHigh-dose methotrexateLeucovorinMethotrexatePharmacokinetics

Identifiers

PMID27496039
PMCPMC5153332
OpenAlexW2493103431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.